(2014). Predictive Role of the Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib. Asian Pacific Journal of Cancer Prevention, 15(2), 1063-1064.
MLA
. "Predictive Role of the Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib", Asian Pacific Journal of Cancer Prevention, 15, 2, 2014, 1063-1064.
HARVARD
(2014). 'Predictive Role of the Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib', Asian Pacific Journal of Cancer Prevention, 15(2), pp. 1063-1064.
CHICAGO
, "Predictive Role of the Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib," Asian Pacific Journal of Cancer Prevention, 15 2 (2014): 1063-1064,
VANCOUVER
Predictive Role of the Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib. Asian Pacific Journal of Cancer Prevention, 2014; 15(2): 1063-1064.
)